Abcam plc (ABC) Ord 0.2p
Share news, reports & tips
6 April 2021 11:03
(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a global distribution agreement with Abcam, it announced on Tuesday, to sell its recently-developed SARS-CoV-2...
12 January 2021 13:14
(Sharecast News) - Clarkson: JP Morgan downgrades to neutral with a target price of 2,960p.
17 December 2020 13:13
(Sharecast News) - Yellow Cake: Berenberg reiterates buy with a target price of 300p.
9 November 2020 11:46
(Sharecast News) - RBC Capital Markets has downgraded its rating on life sciences firm Abcam, sending the shares lower.
22 October 2020 13:59
(Sharecast News) - Abcam: Berenberg downgrades to hold with a target price of 1,180p.
22 October 2020 12:07
(Sharecast News) - Analysts at Berenberg lowered ABCAM to 'hold' from 'buy' on Thursday, highlighting what it called "the real Covid-19 impact".
22 September 2020 13:28
(Sharecast News) - Imperial Brands: RBC Capital Markets upgrades to outperform with a target price of 1,900.0p.
10 July 2020 13:26
(Sharecast News) - Ocado: Berenberg reiterates buy with a target price of 2,225.0p.
20 April 2020 13:41
(Sharecast News) - Abcam: RBC Capital Markets upgrades to outperform with a target price of 1,300p.
20 April 2020 10:02
(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.
9 March 2020 15:48
(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results...
4 March 2020 10:26
(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.